These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9876101)

  • 1. Complement activation as a cause of transient hypotension during plasmapheresis.
    Shiga Y; Fujihara K; Onodera H; Nagata T; Itoyama Y
    Artif Organs; 1998 Dec; 22(12):1067-9. PubMed ID: 9876101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension.
    Slotman GJ; Burchard KW; Williams JJ; D'Arezzo A; Yellin SA
    Surgery; 1986 Jun; 99(6):744-51. PubMed ID: 3520916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of complement activation during membrane-based plasmapheresis procedures.
    Burnouf T; Eber M; Kientz D; Cazenave JP; Burkhardt T
    J Clin Apher; 2004; 19(3):142-7. PubMed ID: 15493055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of complement activators and elucidation of the fate of complement activation products during extracorporeal plasma purification therapy.
    Fadul JE; Alarabi AA; Wikström B; Danielson BG; Nilsson B
    J Clin Apher; 1998; 13(4):167-73. PubMed ID: 9886796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmapheresis-related hypotension.
    Yeh JH; Chiu HC
    Artif Organs; 2000 Sep; 24(9):705-9. PubMed ID: 11012540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of C3a and C5a in hemapheresis procedures].
    Schooneman F; Marchand M; Vigneron C; Streiff F
    Ann Med Interne (Paris); 1990; 141(7):597-9. PubMed ID: 2085237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.
    Chenoweth DE; Cooper SW; Hugli TE; Stewart RW; Blackstone EH; Kirklin JW
    N Engl J Med; 1981 Feb; 304(9):497-503. PubMed ID: 7453783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrupt complement activation and transient neutropenia in patients with acute myocardial infarction treated with streptokinase.
    Frangi D; Gardinali M; Conciato L; Cafaro C; Pozzoni L; Agostoni A
    Circulation; 1994 Jan; 89(1):76-80. PubMed ID: 7741820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic study of serial double-filtration plasmapheresis.
    Yeh JH; Chen WH; Chiu HC
    J Clin Apher; 2002; 17(1):33-7. PubMed ID: 11948704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The possibility of improving biocompatibility by removing anaphylatoxins from the circuit of blood-perfused artificial organs.
    Oka T
    ASAIO Trans; 1989; 35(4):778-83. PubMed ID: 2611046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatibility of different hemodialysis and plasmapheresis membranes.
    Jørstad S
    Blood Purif; 1987; 5(2-3):123-37. PubMed ID: 3497645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunoadsorption therapy for myasthenia gravis: study on the adsorption capacity of an immunoadsorption column].
    Yeh JH; Chiu HC
    J Microbiol Immunol Infect; 1999 Jun; 32(2):121-5. PubMed ID: 11565565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of the different vascular accesses used for double-filtration plasmapheresis.
    Yeh JH; Chen WH; Chiu HC
    J Clin Apher; 2001; 16(3):125-9. PubMed ID: 11746538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fractional plasmapheresis in therapeutic experience: methodological approach].
    Ibragimov AZ
    Klin Med (Mosk); 1997; 75(4):32-4. PubMed ID: 9229629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease.
    Belmont HM; Hopkins P; Edelson HS; Kaplan HB; Ludewig R; Weissmann G; Abramson S
    Arthritis Rheum; 1986 Sep; 29(9):1085-9. PubMed ID: 3489467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.
    Okamiya S; Ogino M; Ogino Y; Irie S; Kanazawa N; Saito T; Sakai F
    Ther Apher Dial; 2004 Jun; 8(3):248-53. PubMed ID: 15154879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between double-filtration plasmapheresis and immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis.
    Yeh JH; Chiu HC
    J Neurol; 2000 Jul; 247(7):510-3. PubMed ID: 10993491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylatoxins C3a and C5a adsorption on acrylonitrile membrane of hollow-fiber and plate dialyzer--an in vivo study.
    Kandus A; Ponikvar R; Drinovec J; Kladnik S; Ivanovich P
    Int J Artif Organs; 1990 Mar; 13(3):176-80. PubMed ID: 2347666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation during tryptophan immunoadsorption treatment.
    Alarabi AA; Nilsson B; Nilsson U; Wikström B; Danielson BG
    Artif Organs; 1993 Sep; 17(9):782-6. PubMed ID: 8240071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation from protamine sulfate administration after coronary angiography.
    Click RL; Homburger HA; Bove AA
    Cathet Cardiovasc Diagn; 1989 Apr; 16(4):221-5. PubMed ID: 2785004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.